Switch View
© Globe Newswire
07.11.2025
ISIN: US3596161097
Fulcrum Therapeutics Inc
FULC
LISTED
NASDAQ
Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
News Preview
CAMBRIDGE, Mass., Nov. 07, 2025 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc.® (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of patients with genetically defined rare diseases, today announced that the company granted non-statutory stock options to two new employees. Fulcrum...
Themefolio
Profiler
Peergroup
© Globe Newswire
07.11.2025
ISIN: US0396971071
Ardelyx Inc
ARDX
LISTED
NASDAQ
Real-World Evidence Studies of XPHOZAH® (tenapanor) Demonstrate Patient Satisfaction and Reduction in Serum Phosphate with XPHOZAH in Data Presented at ASN Kidney Week
News Preview
WALTHAM, Mass., Nov. 07, 2025 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant unmet medical needs, today announced that the company presented data, including results from the first real-world study...
Themefolio
Profiler
Peergroup
© Globe Newswire
07.11.2025
ISIN: IL0011681371
Nano-X Imaging Ltd
NNOX
LISTED
NASDAQ
Nanox to Report Third Quarter 2025 Financial Results on November 20, 2025
News Preview
Nanox to Report Third Quarter 2025 Results on November 20, 2025....
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Short sale statistics, hedge fund activities and much more user-friendly information
© Globe Newswire
07.11.2025
ISIN: US92337R1014
Vera Therapeutics Inc
VERA
LISTED
NASDAQ
Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
News Preview
BRISBANE, Calif., Nov. 07, 2025 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA) today announced that, on November 4, 2025, the Compensation Committee of the Board of Directors of Vera Therapeutics granted inducement awards consisting of non-qualified stock options to purchase 79,050 shares of Class A common stock and restricted stock u...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© Globe Newswire
07.11.2025
ISIN: US00773J2024
Spyre Therapeutics Inc
SYRE
LISTED
NASDAQ
Spyre Therapeutics Announces Grants of Inducement Awards
News Preview
WALTHAM, Mass., Nov. 07, 2025 (GLOBE NEWSWIRE) -- Spyre Therapeutics, Inc. (NASDAQ: SYRE) (the “Company” or “Spyre”), a clinical-stage biotechnology company pioneering long-acting antibodies and antibody combinations to redefine the standard of care for inflammatory bowel disease (“IBD”) and rheumatic diseases, today announced that Spyre’s indepe...
Themefolio
Profiler
Peergroup
© Globe Newswire
07.11.2025
ISIN: NL00150012L7
NewAmsterdam Pharma Company N.V.
NAMS
LISTED
NASDAQ
NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
News Preview
NAARDEN, The Netherlands and MIAMI, Nov. 07, 2025 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or the “Company”), a late-stage, clinical biopharmaceutical company developing oral, non-statin medicines for patients at risk of cardiovascular disease (“CVD”) with elevated low-density lipoprotein cholesterol (“...
Themefolio
Profiler
Peergroup
© BusinessWire
07.11.2025
ISIN: US4577301090
Inspire Medical Systems Inc
INSP
LISTED
NYSE
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Inspire Medical Systems
News Preview
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Inspire Medical Systems, Inc. (“Inspire Medical” or the “Company”) (NYSE: INSP) and reminds investors of the January 5, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Com...
Themefolio
Profiler
Peergroup
© Newsfile
07.11.2025
ISIN: US00857U1079
agilon health inc
AGL
LISTED
NYSE
ROSEN, LEADING INVESTOR COUNSEL, Encourages agilon health, inc. Investors to Inquire About Securities Class Action Investigation - AGL
News Preview
New York, New York--(Newsfile Corp. - November 7, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of agilon health, inc. (NYSE: AGL) resulting from allegations that agilon health may have issued materially misleading business information to the inves...
Themefolio
Profiler
Peergroup
© PR Newswire
07.11.2025
ISIN: US15135B1017
Centene Corp
CNC
LISTED
NYSE
Carolina Complete Health and Centene Foundation Make $200,000 Investment to Help Tackle Food Insecurity in North Carolina
News Preview
Investment strengthens community food resources for families struggling to access healthy meals
CHARLOTTE, N.C., Nov. 7, 2025 /PRNewswire/ -- Carolina Complete Health and Centene Foundation, the philanthropic arm of Centene Corporation (NYSE: CNC), today announc...
Themefolio
Profiler
Peergroup
© BusinessWire
07.11.2025
ISIN: US4718712023
Jasper Therapeutics, Inc.
JSPR
LISTED
NASDAQ
JSPR Deadline: Rosen Law Firm Urges Jasper Therapeutics, Inc. (NASDAQ: JSPR) Stockholders to Contact the Firm for Information About Their Rights
News Preview
Rosen Law Firm, a global investor rights law firm, reminds investors there is a class action lawsuit on behalf of purchasers of securities of Jasper Therapeutics, Inc. (NASDAQ: JSPR), between November 30, 2023 and July 3, 2025. Jasper is a clinical-stage biotechnology company.
For more information, submit a form, email attorney Phillip Kim, or gi...
Themefolio
Profiler
Peergroup
© BusinessWire
07.11.2025
ISIN: US4577301090
Inspire Medical Systems Inc
INSP
LISTED
NYSE
Robbins Geller Rudman & Dowd LLP Announces a Class Action Lawsuit Has Been Filed Against Inspire Medical Systems, Inc. (INSP)
News Preview
The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Inspire Medical Systems, Inc. (NYSE: INSP) common stock between August 6, 2024 and August 4, 2025, inclusive (the “Class Period”), have until January 5, 2026 to seek appointment as lead plaintiff of the Inspire Medical class action lawsuit. Captioned Cit...
Themefolio
Profiler
Peergroup
© PR Newswire
07.11.2025
ISIN: US2521311074
Dexcom Inc
DXCM
LISTED
NASDAQ
DXCM Investor Alert: Kessler Topaz Meltzer & Check, LLP Urges DXCM Investors with Losses to Contact the Firm
News Preview
RADNOR, Pa., Nov. 7, 2025 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against DexCom, Inc. ("DexCom") (NASDAQ: DXCM) on behalf of those who purchased or otherwise acquired DexCom securities between Ju...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© Newsfile
07.11.2025
ISIN: US8753722037
Tandem Diabetes Care Inc
TNDM
LISTED
NASDAQ
ROSEN, LEADING TRIAL ATTORNEYS, Encourages Tandem Diabetes Care, Inc. Investors to Inquire About Securities Class Action Investigation - TNDM
News Preview
New York, New York--(Newsfile Corp. - November 7, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Tandem Diabetes Care, Inc. (NASDAQ: TNDM) resulting from allegations that Tandem Diabetes Care may have issued materially misleading business information...
Themefolio
Profiler
Peergroup
© Globe Newswire
07.11.2025
ISIN: BE0003874915
Fagron NV
FAGR
LISTED
EURONEXT
Fagron’s share buy-back program: Weekly update
News Preview
Regulated informationNazareth (Belgium)/Rotterdam (The Netherlands), 7 November 2025 – 6PM CET...
Themefolio
Profiler
Peergroup
© PR Newswire
07.11.2025
ISIN: KYG0146B1032
Akeso, Inc.
9926
LISTED
HKSE
Akeso Unveils Promising Preclinical Data for IL-1RAP Targeting Antibody (AK135) at SITC 2025
News Preview
HONG KONG, Nov. 7, 2025 /PRNewswire/ -- Akeso, Inc. (HKEX: 9926.HK) published the preclinical research data for its novel antagonistic monoclonal antibody targeting IL-1RAP, AK135, at the 40th Annual Meeting of the Society for Immunotherapy of Cancer (SITC) held in National Harbor, Maryland.
The r...
Themefolio
Profiler
Peergroup
© PR Newswire
07.11.2025
ISIN: KYG0146B1032
Akeso, Inc.
9926
LISTED
HKSE
Ivonescimab HARMONi-A Study Final OS Analysis Results Presented at SITC 2025 with OS HR=0.74
News Preview
The HARMONi-A study is the first Phase III trial of an immunotherapy for EGFR-TKI-resistant, EGFR-mutated non-squamous NSCLC to show statistically significant and clinically meaningful improvements in both progression-free survival (PFS) and overall survival (OS)
With a median follow-up of 32.5...
Themefolio
Profiler
Peergroup
© Globe Newswire
07.11.2025
ISIN: FR0012127173
OSE Immunotherapeutics SA
OSE
LISTED
EURONEXT
OSE Immunotherapeutics Presents a Poster on OSE-Cytomask®, a Novel “Cis-Demasking” Cytokine Technology to Increase Therapeutic Index of Immunocytokines
News Preview
OSE Immunotherapeutics Presents a Poster on OSE-Cytomask®, a Novel
“Cis-Demasking” Cytokine Technology to Increase Therapeutic Index of Immunocytokines...
Themefolio
Profiler
Peergroup
© Globe Newswire
07.11.2025
ISIN: FR0010259150
Ipsen SA
IPN
LISTED
EURONEXT
Ipsen - October 2025 - Monthly information relative to the total number of voting rights and shares composing the share capital
News Preview
Monthly information relative to the total number of voting rights and shares composing the share capital...
Themefolio
Profiler
Peergroup
© Globe Newswire
07.11.2025
ISIN: BE0003766806
Ion Beam Applications SA
IBAB
LISTED
EURONEXT
IBA – Regulated information
News Preview
November 7th, 2025...
Themefolio
Profiler
Peergroup
© Globe Newswire
07.11.2025
ISIN: DK0015998017
Bavarian Nordic A/S
BAVA
LISTED
CPH
Bavarian Nordic Announces Major Shareholder Notification from Morgan Stanley
News Preview
COPENHAGEN, Denmark, November 7, 2025 – Pursuant to section 30 of the Danish Capital Markets Act, Bavarian Nordic A/S hereby announces that the Company has received notification from Morgan Stanley that they hold 5,13% of the shares and voting rights in Bavarian Nordic A/S as of October 31, 2025....
Themefolio
Profiler
Peergroup
© Globe Newswire
07.11.2025
ISIN: US16359R1032
Chemed Corp
CHE
LISTED
NYSE
Chemed Corporation Declares Quarterly Dividend of 60 Cents
News Preview
CINCINNATI, Nov. 07, 2025 (GLOBE NEWSWIRE) -- Chemed Corporation (NYSE:CHE) announced today that the Board of Directors has declared a quarterly cash dividend of 60-cents per share on the Company’s capital stock, payable on December 5, 2025, to shareholders of record as of November 17, 2025. This is equal to the dividend paid in August 2025. This...
Themefolio
Profiler
Peergroup
© PR Newswire
07.11.2025
ISIN: US8051111016
Savara Inc
SVRA
LISTED
NASDAQ
FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Savara
News Preview
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Savara To Contact Him Directly To Discuss Their Options
If you purchased or acquired securities in Savara between March 7, 2024 and May 23, 202...
Themefolio
Profiler
Peergroup
© BusinessWire
07.11.2025
ISIN: US8523123052
STAAR Surgical Co
STAA
LISTED
NASDAQ
STAAR Surgical Announces Amendments to Alcon Merger Agreement
News Preview
STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today announced that the Company has agreed with Alcon Inc. (SIX/NYSE: ALC) to amend their merger agreement to allow proactive solicitation by STAAR of third-party proposals to maximize value...
Themefolio
Profiler
Peergroup
© PR Newswire
07.11.2025
ISIN: US8342033094
Soleno Therapeutics Inc
SLNO
LISTED
NASDAQ
Soleno Therapeutics (SLNO) Faces Investor Scrutiny Amid Disappointing VYKATÔ XR Starts, Discontinuations; Shares Down 26% -- Hagens Berman
News Preview
SLNO Investors with Losses Encouraged to Contact Hagens Berman
SAN FRANCISCO, Nov. 7, 2025 /PRNewswire/ -- On November 5, 2025, investors in Soleno Therapeutics, Inc. (NASDAQ: SLNO) saw the price of their shares tumble $18.78 (-28%) after the company reported disappointing information about VYKAT™...
Themefolio
Profiler
Peergroup
© Newsfile
07.11.2025
ISIN: US23282W6057
Cytokinetics Inc
CYTK
LISTED
NASDAQ
SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Cytokinetics
News Preview
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Cytokinetics To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in Cytokinetics between December 27, 2023 and May 6, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi pa...
Themefolio
Profiler
Peergroup
© Newsfile
07.11.2025
ISIN: US4718712023
Jasper Therapeutics, Inc.
JSPR
LISTED
NASDAQ
SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Jasper
News Preview
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Jasper To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in Jasper between November 30, 2023 and July 3, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh...
Themefolio
Profiler
Peergroup
© Newsfile
07.11.2025
ISIN: US5165441032
Lantheus Holdings Inc
LNTH
LISTED
NASDAQ
SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Lantheus
News Preview
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Lantheus To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in Lantheus between February 26, 2025 and August 5, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner...
Themefolio
Profiler
Peergroup
© Newsfile
07.11.2025
ISIN: US05352A1007
Avantor Inc
AVTR
LISTED
NYSE
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Avantor
News Preview
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered In Avantor To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in Avantor between March 5, 2024 and October 28, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilso...
Themefolio
Profiler
Peergroup
© Globe Newswire
07.11.2025
ISIN: US74168J1016
Prime Medicine Inc
PRME
LISTED
NASDAQ
CORRECTION - Prime Medicine Reports Third Quarter 2025 Financial Results and Provides Business Updates
News Preview
-- New preclinical data for PM577 in Wilson’s Disease (WD) to be presented at AASLD; on-track to file IND and/or CTA in H1’26, with initial clinical data expected in 2027 -- -- Nominated PM647 as development candidate for Alpha-1 Antitrypsin Deficiency (AATD); on-track to file IND and/or CTA in mid-2026, with initial clinical data expected in 2027...
Themefolio
Profiler
Peergroup
© Globe Newswire
07.11.2025
ISIN: CA75150G1046
Ramm Pharma Corp.
RAMM
LISTED
CSE
RAMM Pharma Corp. Provides Additional Disclosure in Connection with its Upcoming Special Meeting of Shareholders
News Preview
TORONTO, Nov. 07, 2025 (GLOBE NEWSWIRE) -- RAMM Pharma Corp. (including its wholly owned subsidiaries, the “Company” or “RAMM”) (CSE: RAMM) wishes to supplement the information contained in its management information circular (the “Circular”) dated October 9, 2025 regarding its proposed transaction (the "Transaction”) with The Global South S.A.S...
Themefolio
Profiler
Peergroup
© PR Newswire
07.11.2025
ISIN: US15135B1017
Centene Corp
CNC
LISTED
NYSE
Ambetter of Illinois Offers Health Insurance in Illinois in 2026
News Preview
As Illinois transitions to a new state-based marketplace, Ambetter of Illinois offers affordable health coverage options in 25 counties during open enrollment, starting Nov. 1.
CHICAGO, Nov. 7, 2025 /PRNewswire/ -- Ambetter of Illinois, a product offered by a Centene Corporati...
Themefolio
Profiler
Peergroup
© PR Newswire
07.11.2025
ISIN: KR7328130000
Lunit Inc.
328130
LISTED
KOE
Lunit AI Maps the Tumor-Immune Landscape to Predict Immunotherapy Response and Discover New Antibody Targets at SITC 2025
News Preview
Studies reveal how the Lunit SCOPE
® suite identifies immunotherapy-responsive subtypes, standardizes immune phenotyping, and accelerates antibody-based target discovery
SEOUL, South Korea, Nov. 7, 2025 /PRNewswire/ -- Lunit (KRX:328130), a...
Themefolio
Profiler
Peergroup
© BusinessWire
07.11.2025
ISIN: US02081G2012
Alphatec Holdings Inc
ATEC
LISTED
NASDAQ
ATEC Mourns Passing of Board Member Jeffrey P. Rydin
News Preview
Alphatec Holdings, Inc. (Nasdaq: ATEC) (“ATEC”), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, today announced with great sadness that Jeffrey P. Rydin, a valued member of its Board of Directors, has passed away at age 59, following a lengthy illness.
Mr. Rydin enjoyed nearly three decades of exper...
Themefolio
Profiler
Peergroup
© BusinessWire
07.11.2025
ISIN: US92764N1028
Vir Biotechnology Inc
VIR
LISTED
NASDAQ
Vir Biotechnology to Participate in the Jefferies 2025 London Healthcare Conference
News Preview
Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that Marianne De Backer, M.Sc., Ph.D., MBA, Chief Executive Officer, will present at the Jefferies 2025 London Healthcare Conference on Tuesday, November 18 at 2:00 p.m. GMT / 9:00 a.m. ET / 6:00 a.m. PT in London, United Kingdom.
A live webcast of the presentation will be made available under...
Themefolio
Profiler
Peergroup
© BusinessWire
07.11.2025
ISIN: US86627T1088
Summit Therapeutics Inc
SMMT
LISTED
NASDAQ
Ivonescimab Plus Chemotherapy Demonstrates a Statistically Significant Benefit in Overall Survival with a Hazard Ratio of 0.74 in 2L+ Treatment of Patients with EGFRm NSCLC in HARMONi-A Study Conducted by Akeso in China
News Preview
Summit Therapeutics Inc. (NASDAQ: SMMT) (“Summit,” “we,” or the “Company”) today noted that our partner, Akeso, Inc. (“Akeso,” HKEX Code: 9926.HK) published results from the Phase III HARMONi-A trial, conducted in China and sponsored by Akeso, featuring the novel, potential first-in-class investigational bispecific antibody, ivonescimab. The data...
Themefolio
Profiler
Peergroup
© BusinessWire
07.11.2025
ISIN: US0718131099
Baxter International, Inc.
BAX
LISTED
NYSE
The Baxter Foundation Announces $2.6M Grant to Advance STEM Education in Chicagoland Through Partnership With Northwestern University
News Preview
The Baxter Foundation, the philanthropic arm of Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced the continuation of a partnership with Northwestern University’s School of Education and Social Policy (SESP) to provide science, technology, engineering and math (STEM) programs for students and teachers throughout the Ch...
Themefolio
Profiler
Peergroup
© Globe Newswire
07.11.2025
ISIN: FR0000031577
Virbac SA
VIRP
LISTED
EURONEXT
Virbac : Declaration of the number of shares and voting rights 10/2025
News Preview
DECLARATION OF THE NUMBER OF SHARES AND VOTING RIGHTS...
Themefolio
Profiler
Peergroup
© PR Newswire
07.11.2025
ISIN: US64132R4048
MetaVia Inc
NRBO
LISTED
NASDAQ
MetaVia Presents Positive New Phase 2a Data on Vanoglipel (DA-1241) in Patients with Presumed MASH at the AASLD The Liver Meeting® 2025
News Preview
Oral GPR119 Agonist Demonstrated Clinically Meaningful Reductions in HbA1c, Improvements in Liver Inflammation and Fibrosis, and Favorable Changes in Plasma Lipidomic Profiles
CAMBRIDGE, Mass., Nov. 7, 2025 /PRNewswire/ -- MetaVia Inc. (Nasdaq: MTVA), a clinical...
Themefolio
Profiler
Peergroup
© PR Newswire
07.11.2025
ISIN: US40637H1095
Halozyme Therapeutics Inc
HALO
LISTED
NASDAQ
FDA Approved DARZALEX Faspro® for Adult Patients with High-Risk Smoldering Multiple Myeloma
News Preview
DARZALEX Faspro® is co-formulated with Halozyme's ENHANZE® drug delivery technology
SAN DIEGO, Nov. 7, 2025 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) (Halozyme) today announced that Johnson & Johnson received U.S. Food and Drug Administratio...
Themefolio
Profiler
Peergroup
© BusinessWire
07.11.2025
ISIN: US3755581036
Gilead Sciences Inc
GILD
LISTED
NASDAQ
Gilead Provides Update on Phase 3 ASCENT-07 Study
News Preview
Gilead Sciences, Inc. (Nasdaq: GILD) today announced the Phase 3 ASCENT-07 study investigating Trodelvy® (sacituzumab govitecan-hziy) versus chemotherapy as a first-line treatment post-endocrine therapy in HR+/HER2-negative metastatic breast cancer patients did not meet the primary endpoint of progression-free survival (PFS) as assessed by Blinded...
Themefolio
Profiler
Peergroup
© BusinessWire
07.11.2025
ISIN: US6047491013
Mirum Pharmaceuticals Inc
TKOMF
LISTED
OTC
Mirum Pharmaceuticals Showcases Leadership in Liver Disease Innovation With Data From LIVMARLI® and Volixibat Clinical Programs at AASLD’s The Liver Meeting®
News Preview
Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM), a leading rare disease company, today announced that multiple presentations featuring data from its LIVMARLI (maralixibat) and volixibat clinical programs will be shared during the American Association for the Study of Liver Diseases’ (AASLD) The Liver Meeting®, taking place November 7-11, 2025, in Washi...
Themefolio
Profiler
Peergroup
© PR Newswire
07.11.2025
ISIN: AU0000182552
Ebr Systems Inc.
EBR
LISTED
ASX
EBR Systems Achieves First Enrollments in the WiSE-UP Study for Heart Failure Patients
News Preview
The WiSE-UP post-approval study is gathering real-world evidence from commercially treated patients using the WiSE® left ventricular endocardial pacing (LVEP) system.
Key Highlights:...
Themefolio
Profiler
Peergroup
© PR Newswire
07.11.2025
ISIN: AU0000182552
Ebr Systems Inc.
EBR
LISTED
ASX
EBR Systems Achieves First Enrollments in the WiSE-UP Study for Heart Failure Patients
News Preview
The WiSE-UP post-approval study is gathering real-world evidence from commercially treated patients using the WiSE® left ventricular endocardial pacing (LVEP) system.
Key Highlights:...
Themefolio
Profiler
Peergroup
© PR Newswire
07.11.2025
ISIN: US28036F1057
Edgewise Therapeutics Inc
EWTX
LISTED
NASDAQ
Edgewise Therapeutics to Participate in Upcoming Investor Conferences
News Preview
BOULDER, Colo., Nov. 7, 2025 /PRNewswire/ -- Edgewise Therapeutics, Inc., (Nasdaq: EWTX), a leading muscle disease biopharmaceutical company, today announced that management will participate in the following investor conferences:...
Themefolio
Profiler
Peergroup
© Globe Newswire
07.11.2025
ISIN: US7402944000
Precision Optics Corp, Inc.
POCI
LISTED
NASDAQ
Precision Optics Announces Product Development Agreement to Deliver Next-Generation Augmented Reality Sub-Systems for Fighter Pilots
News Preview
GARDNER, Mass., Nov. 07, 2025 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (NASDAQ: POCI), a leading designer and manufacturer of advanced optical instruments for the medical and defense/aerospace industries, today announced the receipt of a product development order to build sub-assemblies that will support an advanced augmented realit...
Themefolio
Profiler
Peergroup
© Globe Newswire
07.11.2025
ISIN: US09077B1044
Bioatla Inc
BCAB
LISTED
NASDAQ
BioAtla’s Mecbotamab Vedotin (Mec-V), an AXL-targeting ADC, Demonstrates a Median Overall Survival (OS) of 21.5 months in Subtypes of Refractory Soft Tissue Sarcomas
News Preview
— Mec-V demonstrates median OS of 21.5 months in patients with treatment-refractory leiomyosarcoma, liposarcoma, and undifferentiated pleomorphic sarcoma compared with approximately 12 months with approved agents...
Themefolio
Profiler
Peergroup
© Globe Newswire
07.11.2025
ISIN: US19249H1032
Coherus Oncology Inc
CHRS
LISTED
NASDAQ
Coherus Oncology Presents at SITC Clinical Multiomic Biomarker Data for CHS-114, a Highly Selective anti-CCR8 Cytolytic Antibody
News Preview
– CHS-114 demonstrated robust and selective depletion of CCR8+ Tregs as well as favorable immune remodeling in tumor tissue from head and neck squamous cell carcinoma (HNSCC) patients –...
Themefolio
Profiler
Peergroup
© Globe Newswire
07.11.2025
ISIN: US64051A1016
NeOnc Technologies Holdings Inc
NTHI
LISTED
NASDAQ
NeOnc Technologies (Nasdaq: NTHI) to Host Investor Conference Call to Present Data Updates from Ongoing NEO100-1 Phase 1/2a Clinical Trial and Compassionate Use Program
News Preview
CALABASAS, Calif., Nov. 07, 2025 (GLOBE NEWSWIRE) -- NeOnc Technologies Holdings, Inc. (NTHI) (“NeOnc” or the “Company”), a clinical-stage biopharmaceutical company developing novel brain-penetrant therapeutics for patients with malignant brain tumors and central nervous system (CNS) disorders, today announced that it will host an investor confer...
Themefolio
Profiler
Peergroup
© Globe Newswire
07.11.2025
ISIN: US09077V1008
BIOAGE Labs Inc
BIOA
LISTED
NASDAQ
BioAge Labs to Present at Jefferies Global Healthcare Conference in London
News Preview
EMERYVILLE, Calif., Nov. 07, 2025 (GLOBE NEWSWIRE) -- BioAge Labs, Inc. (NASDAQ: BIOA) ("BioAge", "the Company"), a clinical-stage biotechnology company developing therapeutic product candidates for metabolic diseases by targeting the biology of human aging, today announced that the Company will present at the Jefferies Global Healthcare Conferen...
Themefolio
Profiler
Peergroup
© BusinessWire
07.11.2025
ISIN: VGG312491084
Establishment Labs Holdings Inc
ESTA
LISTED
NASDAQ
Establishment Labs to Present at Jefferies London Healthcare Conference
News Preview
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced its participation in the Jefferies 2025 London Healthcare Conference.
Peter Caldini, Chief Executive Officer, and Raj Denhoy, Chief Financial...
Themefolio
Profiler
Peergroup
© BusinessWire
07.11.2025
ISIN: US30063P1057
Exact Sciences Corp
EXAS
LISTED
NASDAQ
Exact Sciences Announces Breakthrough Results from Landmark Study Demonstrating Superior Early Detection of Liver Cancer with Blood-Based Surveillance Test
News Preview
Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, today announced pivotal clinical validation results from the ALTUS study (NCT: 05064553). The prospective, head-to-head trial demonstrated that the company’s Oncoguard® Liver blood test delivers superior early-stage and overall sensitivity for hepatoc...
Themefolio
Profiler
Peergroup
© BusinessWire
07.11.2025
ISIN: US3755581036
Gilead Sciences Inc
GILD
LISTED
NASDAQ
Gilead’s Livdelzi® Demonstrates Sustained Efficacy in Primary Biliary Cholangitis (PBC), Offering Alkaline Phosphatase (ALP) Reduction, Itch Relief and Potential to Slow Disease Progression
News Preview
Gilead Sciences, Inc. (Nasdaq: GILD) today announced new long-term data reinforcing the safety and efficacy profile of Livdelzi® (seladelpar) for people living with primary biliary cholangitis (PBC). Findings support Livdelzi's consistent efficacy and safety outcomes in patients switching from obeticholic acid and positive impact on liver stiffnes...
Themefolio
Profiler
Peergroup
© BusinessWire
07.11.2025
ISIN: US40131M1099
Guardant Health Inc
GH
LISTED
NASDAQ
Guardant Health to Participate in Upcoming Investor Conferences
News Preview
Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the company will be participating in the following investor conferences.
Jefferies Global Healthcare Conference in London, UK
Fireside chat on Wednesday, November 19 at 9:30 a.m. Greenwich Mean Time
Piper Sandler 37th Annual Healthcare Conference in New...
Themefolio
Profiler
Peergroup
© Globe Newswire
07.11.2025
ISIN: FR0010259150
Ipsen SA
IPN
LISTED
EURONEXT
Ipsen to present two late-breaking sessions at AASLD on new PBC data supporting IQIRVO®’s long-term efficacy, safety and mechanistic insights in fatigue
News Preview
Paris, France – 7 November, 2025 – Ipsen (Euronext: IPN; ADR: IPSEY) today announced that new Primary Biliary Cholangitis (PBC) data with IQIRVO® from the ELATIVE trial1, 2 will be presented in two late-breaking sessions, at The Liver Meeting® 2025, hosted by the American Association for the Study of Liver Diseases (AASLD). ...
Themefolio
Profiler
Peergroup
© BusinessWire
07.11.2025
ISIN: US38341P1021
Gossamer Bio Inc
GOSS
LISTED
NASDAQ
Gossamer Bio to Participate in Upcoming Investor Conferences
News Preview
Gossamer Bio, Inc. (Nasdaq: GOSS), a late-stage, clinical biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD), today announced that the Company will participate in the follow...
Themefolio
Profiler
Peergroup
© PR Newswire
07.11.2025
ISIN: US98956P1021
Zimmer Biomet Holdings Inc
ZBH
LISTED
NYSE
Zimmer Biomet to Present at the Annual Jefferies Global Healthcare Conference in London
News Preview
WARSAW, Ind., Nov. 7, 2025 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that members of the Zimmer Biomet management team will be presenting at the Annual Jefferies Global Healthcare Conference in London on Tuesday, Nov. 18, 2025, at Noon GM...
Themefolio
Profiler
Peergroup
© Globe Newswire
07.11.2025
ISIN: US04351P1012
Ascendis Pharma A/S
ASND
LISTED
NASDAQ
New Pooled 3-Year Analysis Confirms Sustained, Clinically Meaningful Improvements in Renal Function for TransCon® PTH (Palopegteriparatide)-Treated Adults with Hypoparathyroidism
News Preview
COPENHAGEN, Denmark, Nov. 07, 2025 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced that a new pooled analysis showed sustained and clinically meaningful improvements in renal function in adults with hypoparathyroidism treated with TransCon PTH (palopegteriparatide) through Year 3 of the Company’s Phase 2 PaTH Forward and Ph...
Themefolio
Profiler
Peergroup
© Globe Newswire
07.11.2025
ISIN: SG9999014716
WAVE Life Sciences Ltd
WVE
LISTED
NASDAQ
Wave Life Sciences to Present at Upcoming Investor Conferences
News Preview
CAMBRIDGE, Mass., Nov. 07, 2025 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health, today announced that members of Wave’s management team are scheduled to participate in two upcoming investor conferences in November....
Themefolio
Profiler
Peergroup
© BusinessWire
07.11.2025
ISIN: US68622V1061
Organon & Co
OGN
LISTED
NYSE
Organon Announces Agreement to Divest its JADA® System for Up to $465 Million to Laborie
News Preview
Organon (NYSE: OGN), (“Organon” or “the Company”) a global healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day, announced today that it has entered into an agreement with Laborie Medical Technologies Corp. (“Laborie”), a leading diagnostic and therapeutic medical technology company, for them to...
Themefolio
Profiler
Peergroup
© Globe Newswire
07.11.2025
ISIN: US00166B1052
ALX Oncology Holdings Inc
ALXO
LISTED
NASDAQ
ALX Oncology Reports Third Quarter 2025 Financial Results and Provides Corporate Update
News Preview
SOUTH SAN FRANCISCO, Calif., Nov. 07, 2025 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc., (“ALX Oncology” or “the Company”) (Nasdaq: ALXO), a clinical-stage biotechnology company advancing a pipeline of novel therapies designed to treat cancer and extend patients’ lives, today reported financial results for the third quarter ended September 30,...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
